UNSPSC 51286402: Pecocycline

This classification denotes an antibiotic with the molecular formula C29H35N3O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0CG6O25ZC4, chemically known as n-((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene carboxamido)-methyl)nipecotic acid but more generally known as pecocycline, which bears US NIH Compound Identifier 5745800. European Medicines Agency schedules Pecocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09644MIG.

The term PECOCYCLINE is an International Non-Proprietary Name. PECOCYCLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC12C(CC3C(O)(C4C(C(=C3C1=O)O)C(O)CCC4)C)C(N(C)C)C(=O)C(=C(\O)NCN1CC(CCC1)C(=O)O)\C2=O.

UNSPSC 51286402 Pecocycline is a Commodity code that captures pharmaceutical products and related supplies acquired by state and local health agencies. Recent state and local opportunities tagged under this code show purchasing of specific antibiotic and emergency-response pharmaceuticals—including doxycycline hyclate tablets and naloxone delivery systems—rather than the pecocycline product name alone. State health departments and county public health jurisdictions are the primary issuing bodies, procuring through competitive bidding processes (IFB and ITB) and cooperative purchasing vehicles such as MMCAP Infuse consortiums. Quantities range from hundreds to thousands of units annually, with contracts typically structured as initial multi-year terms with renewal options. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify authorization, and appropriate insurance coverage; no explicit set-aside designations appear in the recent records.

Illinois and Florida represent the documented geographic activity in the recent opportunities block. The Illinois Department of Public Health awarded a $2.999 million, three-year piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (closed award, not an open solicitation) for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets under IFB 26-482DPH-PREPD-B-53392. Seminole County, Florida released an IFB (60459723LAS) posted June 30, 2026 with response due July 26, 2023 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the county notes potential FEMA funding and requires inclusion of all shipping costs in vendor pricing.